Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0000950170-24-069401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2024-06-05 | 2024-06-03+ | BBIO | Scott Randal W. | Dir | S - Sale | $30.32 | -2,500 | 5,700 | -30% | -$75.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | S | D | 200 | $29.48 | 5,500 | I By Thinking Bench Capital LLC | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $29.44 to $29.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-06-04 | S | D | 1,500 | $31.30 | 4,000 | I By Thinking Bench Capital LLC | — | — | |
| 3 | Common | Common Stock | 2024-06-03 | S | D | 800 | $28.68 | 5,700 | I By Thinking Bench Capital LLC | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $28.31 to $29.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |